Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CVS Health Corp
(NY:
CVS
)
104.72
-0.09 (-0.09%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CVS Health Corp
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
70
71
Next >
10 Worst Performing Large-Caps Last 12 Months
↗
January 09, 2025
Here’s this week’s top ten worst performing Large-Caps in the last twelve months.
Via
Talk Markets
Topics
Stocks / Equities
After Falling More Than 40% in 2024, Can CVS Health Stock Turn Things Around This Year?
↗
January 09, 2025
Via
The Motley Fool
Market Whales and Their Recent Bets on CVS Options
↗
January 08, 2025
Via
Benzinga
8 Health Care Stocks Whale Activity In Today's Session
↗
January 08, 2025
Via
Benzinga
Under the Radar: Undervalued Assets Wall Street Isn't Talking About
↗
January 07, 2025
Via
Benzinga
Breaking Down CVS Health: 14 Analysts Share Their Views
↗
January 06, 2025
Via
Benzinga
CVS Health Unusual Options Activity For December 30
↗
December 30, 2024
Via
Benzinga
Market Whales and Their Recent Bets on CVS Options
↗
December 26, 2024
Via
Benzinga
Peering Into CVS Health's Recent Short Interest
↗
December 19, 2024
Via
Benzinga
CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
↗
January 06, 2025
CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and injunctions.
Via
Benzinga
Topics
Lawsuit
How Cigna Remains at the Top of the Health Insurance Food Chain
January 06, 2025
The Cigna Group has been agile and nimbly navigating the trends in managed care as it unloaded its Medicare Advantage business before the storm hit its peers.
Via
MarketBeat
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
↗
January 03, 2025
Via
Benzinga
10 Worst Performing Large-Caps Last 12 Months
↗
January 02, 2025
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months.
Via
Talk Markets
Topics
Stocks / Equities
A Closer Look at CVS Health's Options Market Dynamics
↗
December 17, 2024
Via
Benzinga
10 High Yield Dividend Compounders To Buy Now
↗
December 31, 2024
High yield securities are thought of primarily as income generators. But less attention is paid to their ability to compound income over time.
Via
Talk Markets
Topics
Stocks / Equities
10 High-Yield Stocks For Lasting Retirement Income
↗
December 27, 2024
High dividend stocks are naturally appealing for income investors such as retirees. High yield stocks can provide higher levels of retirement income.
Via
Talk Markets
Topics
Retirement
Stocks / Equities
CVS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CVS Health Corporation - CVS
December 21, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
The Drugstore Industry Is Definitely Suffering, But Don’t Count It Out Just Yet
↗
December 21, 2024
Drugstores are not the investment darlings they used to be. They’ve been struggling for years – more than a decade, actually – and those struggles are now front and center. But don't count out the...
Via
Talk Markets
Topics
Stocks / Equities
Benzinga Bulls And Bears: Tesla, Broadcom, UnitedHealth, Bitcoin And Dogecoin Bull 'Had To Sell' After Price Plunge
↗
December 21, 2024
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories. Major averages jumped on Friday but still logged weekly losses, with...
Via
Benzinga
Topics
Stocks
Agree Realty Stock: Buy, Sell, or Hold?
↗
December 21, 2024
Via
The Motley Fool
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
↗
December 19, 2024
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending.
Via
Benzinga
CVS Shares Are Falling Today: What's Going On?
↗
December 19, 2024
CVS Health Corporation's stock (NYSE: CVS) is trading lower Thursday amid news of a lawsuit filed by the U.S. Department of Justice (DOJ) against CVS Pharmacy Inc., a subsidiary of CVS Health. Here's...
Via
Benzinga
Topics
Lawsuit
CVS Faces DOJ Lawsuit Alleging Violations Of Controlled Substances Act And False Claims Act Over Opioid Prescriptions
↗
December 19, 2024
The U.S. Department of Justice filed a civil complaint against CVS Pharmacy Inc owned by CVS Health Corp, alleging the nation's largest pharmacy chain violated the Controlled Substances Act by filling...
Via
Benzinga
Topics
Lawsuit
Pharmacy Benefit Managers Played Key Role in Worsening Opioid Crisis, Drug Makers Paid Staggering Rebates To Middlemen: NYT
↗
December 18, 2024
An investigation uncovers how pharmacy benefit managers' rebate deals with opioid manufacturers undermined safeguards, worsening America's overdose crisis.
Via
Benzinga
What's Going On With CVS Health, UnitedHealth And Cigna Group Shares?
↗
December 17, 2024
Shares of Pharmacy-benefit managers (PBMs) including CVS Health Corp (NYSE:CVS), UnitedHealth Group Inc (NYSE:UNH) and Cigna Group (NYSE:CI) are moving lower Tuesday on continued downside pressure...
Via
Benzinga
Topics
Government
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
↗
December 17, 2024
Via
Benzinga
CVS, Cigna, UnitedHealth Shares Slide As Trump Targets Drug 'Middleman'
↗
December 16, 2024
Shares of CVS Health Corp (NYSE:CVS), Cigna Group (NYSE:CI) and UnitedHealth Group Inc (NYSE:UNH) are falling Monday afternoon after President-elect Donald Trump said he plans to target...
Via
Benzinga
Topics
Government
9 Health Care Stocks With Whale Alerts In Today's Session
↗
December 16, 2024
Via
Benzinga
Is Walgreens Boots Alliance a Millionaire Maker?
↗
December 15, 2024
The company could soon start growing earnings again, offering investors an 11% dividend yield.
Via
The Motley Fool
Joe Rogan On Public Sympathy For UnitedHealthcare CEO Murder Suspect: Health Insurance A 'Dirty, Dirty Business'
↗
December 12, 2024
Joe Rogan stopped short of offering any sympathy for the death of UnitedHealthcare CEO Brian Thompson with criticism of the health insurance sector.
Via
Benzinga
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
70
71
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.